The FEATURE study provides the first prospective validation of FDG-PET/CT and PERCIST response criteria in patients presenting with bone-only or bone-dominant metastatic breast cancer, opening the ...
Efficacy of systemic therapy following [177Lu] Lu-PSMA in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). This is an ASCO Meeting Abstract from the 2023 ASCO Genitourinary ...
Gray, PhD, a central figure in ECOG-ACRIN Cancer Research Group for more than 25 years, has retired from his position as Group Statistician, Therapeutics. Dr. Gray will continue to serve the group in ...
The research teams developed multimodal models to more precisely stratify recurrence risk in early-stage breast cancer. The models integrate histopathologic imaging, clinical, and molecular data ...
Oncology physicians' knowledge, attitudes, and practices regarding fertility preservation. Background: The ECOG PS scale is a widely used measure of functional status in oncology and is a good ...
New AI models integrating imaging, clinical, and molecular data from the TAILORx tissue biorepository show stronger prognostic performance than current methods to predict recurrence risk in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results